Drugs, Inc. recently received approval from the Food and Drug Administration for its new supplemental drug application for a 300-milligram tablet of an antiplatelet treatment. The company invested $170 thousand in the research and development fund for this drug application 7 years ago. What is the present worth of the investment now, if the company achieves a rate of return of 2% per year?